Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment

2003 ◽  
Vol 12 (9) ◽  
pp. 1511-1519 ◽  
Author(s):  
Hagit Eldar-Finkelman ◽  
Ronit Ilouz
Keyword(s):  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Glycogen Synthase ◽  
Glycogen Synthase Kinase ◽  
Glycogen Synthase Kinase 3 ◽  
Diabetes Treatment ◽  
Challenges And Opportunities ◽  
Type 2 Diabetes Treatment

scholarly journals Molecular docking analysis of compounds from Justica adhatoda L with glycogen synthase kinase-3 β

2020 ◽  
Vol 16 (11) ◽  
pp. 893-899
Author(s):  
Selvaraj Jayaraman ◽  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Molecular Docking ◽  
Glycogen Synthase ◽  
Analysis Data ◽  
Glycogen Synthase Kinase ◽  
Glycogen Synthase Kinase 3 ◽  
Docking Analysis ◽  
Molecular Docking Analysis

Type 2 diabetes mellitus (T2DM) is linked with Glycogen synthase kinase-3 β.Therefore, it is ofinterest to document molecular docking analysis data of compounds from Justica adhatoda L with glycogen synthase kinase-3 β. We report the binding features of ethambutol, pyrazinamide, stigmasterol and vasicoline with GSK-3 β.

scholarly journals Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes

Diabetes ◽  
2000 ◽  
Vol 49 (2) ◽  
pp. 263-271 ◽  
Author(s):  
S. E. Nikoulina ◽  
T. P. Ciaraldi ◽  
S. Mudaliar ◽  
P. Mohideen ◽  
L. Carter ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Skeletal Muscle ◽  
Potential Role ◽  
Glycogen Synthase ◽  
Glycogen Synthase Kinase 3 ◽  
Muscle Insulin Resistance ◽  
Skeletal Muscle Insulin Resistance
Sign in / Sign up

Export Citation Format

Share Document